SCHEMBL1556937

SCHEMBL1556937

CCC(CC)(c1ccccc1)P(=O)(O)O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.52
TSHR P16473 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
KMT2A Q03164 1/20 0.44
PGK1 P00558 4/20 0.44
PGK2 P07205 4/20 0.44
FDPS P14324 1/20 0.42
PTPN5 P54829 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
KIF11 P52732 1/20 0.40
HDAC1 Q13547 1/20 0.40
POLB P06746 1/20 0.40
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL8609891 1.00 PTPN1 (0.52) PTPN1TSHRMEN1ALDH1A1GAA
SCHEMBL7870277 0.89 PGK1 (0.44) PTPN1TSHRMEN1ALDH1A1GAA
SCHEMBL3390400 0.86 PGK1 (0.52) PTPN1PGK1PGK2PTPN5
SCHEMBL27794376 0.86 PTPN1 (0.39) PTPN1TSHRMEN1ALDH1A1GAA
SCHEMBL9440261 0.84 ALDH1A1 (0.50) MEN1ALDH1A1KMT2ASMN1; SMN2HDAC1
SCHEMBL5859053 0.83 PTPN5 (0.46) PTPN1PGK1PGK2PTPN5
SCHEMBL31540973 0.82 NPY5R (0.40) PTPN1TSHRALDH1A1GAAPGK1
SCHEMBL2382743 0.82 TSHR (0.43) TSHRALDH1A1GAAPGK1PGK2
SCHEMBL8470305 0.82 PGK1 (0.39) PTPN1TSHRMEN1ALDH1A1GAA
SCHEMBL11406548 0.81 PTPN1 (0.46) PTPN1TSHRMEN1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3592735-B1 AN IMPROVED PROCESS FOR THE PREPARATION OF TETROFOSMIN OR ACID ADDITION SALT THEREOF JUBILANT GENERICS LTD FORMERLY A DIVISION OF JUBILANT LIFE SCIENCES LTD (IN) 2024-03-20 EP claimed
CN-116249520-A Blocking replication of SARS-COV-2 and other pathogenic viruses using WNT/beta-catenin pathway inhibitors 阿尔伯塔大学理事会 2023-06-09 CN claimed
CN-113707933-A Preparation method of solid electrolyte nano dispersion liquid of lithium ion battery and solid electrolyte nano dispersion liquid 北京卫蓝新能源科技有限公司 2021-11-26 CN claimed
US-10836781-B2 Process for the preparation of tetrofosmin or acid salt thereof Jubilant Generics Limited (IN) 2020-11-17 US claimed
EP-2719496-B1 FLUX SENJU METAL INDUSTRY CO (JP) 2018-09-26 EP claimed
WO-2018162964-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF TETROFOSMIN OR ACID ADDITION SALT THEREOF JUBILANT GENERICS LIMITED (FORMERLY A DIVISION OF JUBILANT LIFE SCIENCES LIMITED) (IN) 2018-09-13 WO claimed
US-9227187-B2 Method for preparing proton-conducting inorganic particles COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2016-01-05 US claimed
US-20140113982-A1 METHOD FOR PREPARING PROTON-CONDUCTING INORGANIC PARTICLES Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2014-04-24 US claimed
EP-2647013-A1 METHOD FOR PREPARING PROTON CONDUCTING INORGANIC PARTICLES Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) 2013-10-09 EP claimed
WO-2012072572-A1 METHOD FOR PREPARING PROTON CONDUCTING INORGANIC PARTICLES Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2012-06-07 WO claimed
EP-4269543-B1 POLYSILOXANE HYDRAULIC FLUIDS COMMW SCIENT IND RES ORG (AU) 2026-03-04 EP disclosed
WO-2025133100-A1 PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE PREPARATION OF TAPINAROF INTERQUIM, S.A. (ES) 2025-06-26 WO disclosed
US-12227713-B2 Polysiloxane hydraulic fluids THE BOEING COMPANY (US) 2025-02-18 US disclosed
US-20250011671-A9 POLYSILOXANE HYDRAULIC FLUIDS THE BOEING COMPANY 2025-01-09 US disclosed
US-12159967-B2 Nonaqueous electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-12-03 US disclosed
US-4892949-A ORGANIC PHOTOCONDUCTORS RICOH COMPANY, LTD. (JP) 1990-01-09 US disclosed
US-4859556-A MULTILAYER; ELECTROCONDUCTIVE SUPPORT WITH PHOTOSENSITIVE MATERIAL RICOH COMPANY, LTD. (JP) 1989-08-22 US disclosed
EP-0068378-B1 NOVEL IMIDAZO(1,2-A)PYRIDINES AND PYRAZINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1986-03-05 EP disclosed
US-4450164-A ANTIULCER AND ANTISECRETORY AGENTS SCHERING CORPORATION (US) 1984-05-22 US disclosed
EP-0068378-A1 Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them SCHERING CORPORATION (US) 1983-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10836781-B2 Process for the preparation of tetrofosmin or acid salt thereof SLC6A3, SLC6A5, SLC6A6 PTPN1 966/4885TSHR 1966/4885MEN1 399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.